2000
Site Expansion to Feature Patient Information on Cardiac Arrhythmias Indianapolis, IN - To increase patient awareness of lifesaving and life-enhancing therapy options for cardiac arrhythmias and...
Indianapolis, Ind. and Cupertino, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the development of minimally invasive technology to treat coronary artery disease, announced...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today CE Mark approval of its MULTI-LINK...
Indianapolis, Ind. and Tokyo, Japan - In an effort to broaden and accelerate the access of Guidant's lifesaving and life-enhancing medical technologies to the Japanese population, Guidant...
Nearly 75% of Patients Treated with ANCURE Bifurcated System Implant Experience Decreasing Aneurysm Size Over Time Indianapolis, IN - Three-year follow-up data on Guidant's (NYSE and PCX: GDT)...
Indianapolis, Ind. and Santa Clara, Calif. - Clinical data from a recent clinical trial sponsored by Guidant Corporation (NYSE and PCX: GDT) demonstrate that coronary stenting is a safe and...
Biliary Stent Further Extends Company''s Line of Non-Coronary Stent Systems Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
PRIZM 2 and MULTI-LINK TETRA Provide Foundation for Fourth Quarter Growth Indianapolis, IN - Reporting strong implantable defibrillator, pacemaker, and angioplasty revenues as well as growth from...
Diagnosing Abdominal Aortic Aneurysms A Growing Concern for Family and Primary Care Physicians Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its third quarter 2000 earnings conference call on...
Innovative, New System Represents Guidant''s Eighth Major Product Approval in Four Months. Market Anticipation of New Coronary Stent Impacts Third Quarter Revenues Indianapolis, Ind. and Santa...
National Institute for Clinical Excellence Recommends Three-Fold Increase in Defibrillator Use Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary and peripheral vascular disease, today announced the start of a clinical trial to determine...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that Guidant president and CEO Ron Dollens has been named to the board of directors of the Alliance for Aging Research....
Company to Make Acquisition Decision After Completing Comprehensive Investigation Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry,...
Screening for Abdominal Aortic Aneurysm Also Available in Select Sites for the First Time Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implants of...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received U.S. Food and...
Study Examines Alternative Treatment for Hypertension Caused by Renal Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Patients suffering from high blood pressure caused by renal artery...
Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study show that a new procedure utilizing endoscopic vein harvesting leads to fewer wound healing complications compared to...
INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its planned general briefing at the upcoming American...
Clinical Trial Will Assess Stenting of Cerebral Arteries Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of vascular disease,...
Key Opinion Leaders Attend Day-Long Opening Symposium, Witness Remote Broadcasts of Live Case Demonstrations Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a leading provider of...
World's Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced worldwide market...
Launch of MULTI-LINK PENTA Registry is a Result of Guidant's IDE Filing of Fifth Broad Use Coronary Stent System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...
Guidant Named one of FORTUNE Magazine''s 100 Fastest Growing Companies and IndustryWeek''s 100 Best Managed Companies Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader...
Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the company has received FDA approval to...
World''s Smallest, Most Advanced, Dual-Chamber Implantable Defibrillation System Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the company has...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the worldwide market release of the ZOOM(tm)...
Indianapolis, IN and Santa Clara, CA - As part of its comprehensive program to treat carotid artery disease, Guidant Corporation (NYSE and PCX: GDT) has launched a study to evaluate the safety and...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, is today joining a number of the nation''s leading health care companies and...
Indianapolis, IN and Santa Clara, CA - Patients at risk of experiencing life-threatening abrupt closures in small blood vessels may soon benefit from new technology developed to prevent blocked...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), today announced all-time record sales of $668.4 million for the second quarter of 2000, an increase of 9 percent over the second quarter...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced that the CONTAK CD heart failure device...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced FDA marketing clearance for two new...
Briefing Serves as a Call to Action to Address Significant Health Concern Indianapolis, IN - In an effort to provide increased visibility to a growing public health crisis-cardiovascular disease...
Data from INHIBIT Trial Shows In-Stent Restenosis Reduction With Radiotherapy Indianapolis, Ind. and Santa Clara, Calif. - Results from the INHIBIT (INtimal Hyperplasia Inhibition with Beta...
Landmark Study Examines Minimally Invasive Alternative for Treating Carotid Artery Disease Indianapolis, Ind., Santa Clara, Calif. and Newark, N.J. - Guidant Corporation (NYSE and PCX: GDT) and...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today that is has filed with the U.S....
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of medical technology for the treatment of cardiovascular and vascular disease, today announced...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiovascular technologies that save and improve lives, today announced that it has received...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced the enrollment of the first...
Indianapolis, IN and Menlo Park, CA - Two years of clinical data demonstrate that Guidant Corporation''s (NYSE and PCX: GDT) ANCURE(tm) Bifurcated Endograft System is an effective and safe,...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that on October 1, 2000 John C. Jenkins will become Vice President and General Counsel of the company, reporting to...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, commends President Clinton''s Executive Memorandum taking the first step toward...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world-leader in the treatment of cardiovascular disease, announced today that it has agreed with Boston Scientific Corporation on a...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of technologies for the treatment of carotid artery and peripheral vascular...
MULTI-LINK TETRA Coronary Stent System Receives CE Mark Approval Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery...
Indianapolis, IN and Santa Clara, CA - Patients suffering from re-occurring blockages in coronary arteries can now look forward to a new technology that has been shown to reduce the recurrence of...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced the start of PACMAN, a multicenter European...